← Back to catalogue

Nacetylprocainamide

FDA UDI

Class II (US FDA UDI)

by Roche Diagnostics Corp.

Identity

Trade Name
Nacetylprocainamide FDA UDI
Generic Name
N-acetylprocainamide therapeutic drug monitoring IVD, kit, enzyme immunoassay (EIA) FDA UDI
Model / Reference
4853954190 FDA UDI

Identifiers

Catalog Number
4853954190 FDA UDI
Primary DI / UDI-DI
04015630998968 FDA UDI
510(k) Number
K060738 FDA UDI
FDA Product Code
LAN FDA UDI
GMDN Term
N-acetylprocainamide therapeutic drug monitoring IVD, kit, enzyme immunoassay (EIA) FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.3320 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: N-acetylprocainamide therapeutic drug monitoring IVD, kit, enzyme immunoassay (EIA)

Nacetylprocainamide by Roche Diagnostics Corp. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as N-acetylprocainamide therapeutic drug monitoring IVD, kit, enzyme immunoassay (EIA).

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI bcfc08e0-a635-4719-998b-cea2efbcdbbd 35 fields · synced Jun 6, 2026